Moreover, exome sequencing of FAT4 in gastric cancer revealed hyper-methylation of the FAT4 promoter, suggesting that epigenetics is a likely mechanism behind FAT4 downregulation [28]. This evidence concerns the gene FAT4 and gastric cancer.